EDITAS MEDICINE, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $36.00K.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $21.00K.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $192.00K.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $11.00K.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $70.00K, a 63.73% decline from fiscal 2024.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $193.00K, a 370.73% increase from fiscal 2023.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $41.00K, a 86.56% decline from fiscal 2022.
- EDITAS MEDICINE, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $305.00K, a 99.03% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $36.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $70.00K 10-K · filed 2026-03-09 | |
| 2025-09-30 | $21.00K 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $193.00K 10-K · filed 2026-03-09 | |
| 2024-03-31 | $192.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $41.00K 10-K · filed 2025-03-05 | |
| 2023-06-30 | $11.00K 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $305.00K 10-K · filed 2025-03-05 | |
| 2022-09-30 | $80.00K 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $218.00K 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $31.50M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $2.50M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $16.57M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $12.00M 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $19.50M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $947.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $6.84M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $3.05M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $14.86M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.33M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $2.89M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $1.53M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $10.33M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $1.74M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.60M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $4.33M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $1.77M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $233.00K 10-K · filed 2019-03-01 | |
| 2015-12-31 | $6.00K 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |